Valsartan,sacubitril
Novartis
[]
 well designed, double-blind study. results are very reassuring and support lack of risk says editor-in-chief of #jaccheartfailure on the perspective trial at #esccongress 
Official account of the American College of Cardiology. Join us to transform cardiovascular care & improve heart health. Find us: @JACCJournals @Cardiology